AcuCort receives its first order of Zeqmelit®
AcuCort has received its first order of the oral film Zeqmelit®. The order value will have a significant positive impact on the company's financial results.– This order signifies a crucial milestone in AcuCort's history, says Jonas Jönmark, CEO of AcuCort.Zeqmelit®, a rapidly dissolving oral film administered on the tongue for the treatment of severe to acute allergies, is in an intensive commercialization phase. Now, the first order has been received. The purchaser is Unimedic Pharma, also responsible for Zeqmelit® sales in the Nordic region. The order includes Zeqmelit® in its three